Endoscopic ultrasound

Charles Dye, Irving Waxman

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Indications and the clinical utility of endosonography have evolved as new technology, such as linear array echoendoscopes and EUS-guided fine needle aspiration, has emerged. The most noteworthy of the EUS applications are for cancer staging; including rectal, pancreatic, lung, and esophageal malignancies. There is little doubt that EUS is a powerful tool for cancer imaging, but its clinical impact in patient care and management has yet to be validated in prospective outcome studies. Other imaging modalities such as positron emission tomography (PET), dual-phased helical CT, and MR imaging technology will undoubtedly provide increasingly accurate diagnostic and staging information for gastrointestinal diseases. EUS imaging alone may assume a less significant role in relation to these noninvasive modalities in the future. EUS-guided FNA, as well as therapeutic EUS applications, will likely continue to expand in scope and play an important role in clinical medicine for many years to come.

Original languageEnglish (US)
Pages (from-to)863-879
Number of pages17
JournalGastroenterology Clinics of North America
Volume31
Issue number3
DOIs
StatePublished - Sep 1 2002

Fingerprint

Patient Care Management
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Technology
Endosonography
Neoplasm Staging
Gastrointestinal Diseases
Spiral Computed Tomography
Clinical Medicine
Fine Needle Biopsy
Positron-Emission Tomography
Neoplasms
Outcome Assessment (Health Care)
Prospective Studies
Lung
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Dye, Charles ; Waxman, Irving. / Endoscopic ultrasound. In: Gastroenterology Clinics of North America. 2002 ; Vol. 31, No. 3. pp. 863-879.
@article{30a5072d5e3f406eaedcbd89403cea47,
title = "Endoscopic ultrasound",
abstract = "Indications and the clinical utility of endosonography have evolved as new technology, such as linear array echoendoscopes and EUS-guided fine needle aspiration, has emerged. The most noteworthy of the EUS applications are for cancer staging; including rectal, pancreatic, lung, and esophageal malignancies. There is little doubt that EUS is a powerful tool for cancer imaging, but its clinical impact in patient care and management has yet to be validated in prospective outcome studies. Other imaging modalities such as positron emission tomography (PET), dual-phased helical CT, and MR imaging technology will undoubtedly provide increasingly accurate diagnostic and staging information for gastrointestinal diseases. EUS imaging alone may assume a less significant role in relation to these noninvasive modalities in the future. EUS-guided FNA, as well as therapeutic EUS applications, will likely continue to expand in scope and play an important role in clinical medicine for many years to come.",
author = "Charles Dye and Irving Waxman",
year = "2002",
month = "9",
day = "1",
doi = "10.1016/S0889-8553(02)00031-6",
language = "English (US)",
volume = "31",
pages = "863--879",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",
number = "3",

}

Endoscopic ultrasound. / Dye, Charles; Waxman, Irving.

In: Gastroenterology Clinics of North America, Vol. 31, No. 3, 01.09.2002, p. 863-879.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Endoscopic ultrasound

AU - Dye, Charles

AU - Waxman, Irving

PY - 2002/9/1

Y1 - 2002/9/1

N2 - Indications and the clinical utility of endosonography have evolved as new technology, such as linear array echoendoscopes and EUS-guided fine needle aspiration, has emerged. The most noteworthy of the EUS applications are for cancer staging; including rectal, pancreatic, lung, and esophageal malignancies. There is little doubt that EUS is a powerful tool for cancer imaging, but its clinical impact in patient care and management has yet to be validated in prospective outcome studies. Other imaging modalities such as positron emission tomography (PET), dual-phased helical CT, and MR imaging technology will undoubtedly provide increasingly accurate diagnostic and staging information for gastrointestinal diseases. EUS imaging alone may assume a less significant role in relation to these noninvasive modalities in the future. EUS-guided FNA, as well as therapeutic EUS applications, will likely continue to expand in scope and play an important role in clinical medicine for many years to come.

AB - Indications and the clinical utility of endosonography have evolved as new technology, such as linear array echoendoscopes and EUS-guided fine needle aspiration, has emerged. The most noteworthy of the EUS applications are for cancer staging; including rectal, pancreatic, lung, and esophageal malignancies. There is little doubt that EUS is a powerful tool for cancer imaging, but its clinical impact in patient care and management has yet to be validated in prospective outcome studies. Other imaging modalities such as positron emission tomography (PET), dual-phased helical CT, and MR imaging technology will undoubtedly provide increasingly accurate diagnostic and staging information for gastrointestinal diseases. EUS imaging alone may assume a less significant role in relation to these noninvasive modalities in the future. EUS-guided FNA, as well as therapeutic EUS applications, will likely continue to expand in scope and play an important role in clinical medicine for many years to come.

UR - http://www.scopus.com/inward/record.url?scp=0036758645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036758645&partnerID=8YFLogxK

U2 - 10.1016/S0889-8553(02)00031-6

DO - 10.1016/S0889-8553(02)00031-6

M3 - Review article

C2 - 12481735

AN - SCOPUS:0036758645

VL - 31

SP - 863

EP - 879

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 3

ER -